Thermo Fisher Scientific Inc (TMO)
516.10
+3.26
(+0.64%)
USD |
NYSE |
Nov 21, 16:00
516.08
-0.02
(-0.00%)
After-Hours: 20:00
Thermo Fisher Scientific Shareholders Equity (Quarterly): 48.99B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 48.99B |
June 30, 2024 | 47.43B |
March 31, 2024 | 45.52B |
December 31, 2023 | 46.74B |
September 30, 2023 | 45.33B |
June 30, 2023 | 43.75B |
March 31, 2023 | 42.26B |
December 31, 2022 | 43.98B |
September 30, 2022 | 43.55B |
June 30, 2022 | 42.29B |
March 31, 2022 | 40.96B |
December 31, 2021 | 40.79B |
September 30, 2021 | 38.71B |
June 30, 2021 | 36.85B |
March 31, 2021 | 35.06B |
December 31, 2020 | 34.51B |
September 30, 2020 | 31.82B |
June 30, 2020 | 29.88B |
March 31, 2020 | 28.56B |
December 31, 2019 | 29.68B |
September 30, 2019 | 29.36B |
June 30, 2019 | 28.73B |
March 31, 2019 | 27.69B |
December 31, 2018 | 27.59B |
September 30, 2018 | 26.89B |
Date | Value |
---|---|
June 30, 2018 | 26.44B |
March 31, 2018 | 26.12B |
December 31, 2017 | 25.41B |
September 30, 2017 | 24.70B |
June 30, 2017 | 22.39B |
March 31, 2017 | 21.80B |
December 31, 2016 | 21.54B |
September 30, 2016 | 21.66B |
June 30, 2016 | 21.26B |
March 31, 2016 | 20.92B |
December 31, 2015 | 21.35B |
September 30, 2015 | 20.85B |
June 30, 2015 | 20.68B |
March 31, 2015 | 19.91B |
December 31, 2014 | 20.55B |
September 30, 2014 | 20.51B |
June 30, 2014 | 20.66B |
March 31, 2014 | 20.43B |
December 31, 2013 | 16.86B |
September 30, 2013 | 16.44B |
June 30, 2013 | 15.80B |
March 31, 2013 | 15.60B |
December 31, 2012 | 15.46B |
September 30, 2012 | 15.29B |
June 30, 2012 | 15.09B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
28.56B
Minimum
Mar 2020
48.99B
Maximum
Sep 2024
39.83B
Average
41.61B
Median
Shareholders Equity (Quarterly) Benchmarks
Fonar Corp | 168.69M |
XWELL Inc | 6.304M |
ProPhase Labs Inc | 38.13M |
Applied DNA Sciences Inc | 12.39M |
Veracyte Inc | 1.176B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 100.36B |
Total Liabilities (Quarterly) | 51.26B |
Debt to Equity Ratio | 0.7208 |
Current Ratio | 1.629 |
Net Debt Paydown Yield | -0.11% |